Turn Therapeutics Inc. (TTRX)
Data as of , from SEC Form 4 filings.
See up to 3 months of TTRX. The 7-day demo opens the 1M and 3M ranges and puts TTRX on your watchlist.
Start 7-day demoLatest TTRX insider trades
Zuraiz Chaudhary - OfficerOpen-market purchase$9K- Arthur F. Golden - DirectorOpen-market purchase$34K
About Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. files with the SEC under CIK 0002023016 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TTRX Form 4 activity by transaction type, last 90 days
No Form 4 activity for TTRX in the last 90 days.
TTRX insider transactions (Form 4)
2622 Form 4 filings on record, the earliest from Oct 8, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Martin William Dewhurst - Director | Grant or award | Stock option (right to buy) | 71,666 | $0.00 | - | |
 Andrew Gengos - Director | Grant or award | Stock option (right to buy) | 95,000 | $0.00 | - | |
| Arthur F. Golden - Director | Grant or award | Stock option (right to buy) | 89,584 | $0.00 | - | |
 Kent Edward Kester - Director | Grant or award | Stock option (right to buy) | 83,334 | $0.00 | - | |
 Bradley Evan Burnam - Officer | Gift | Common Stock | 300,000 | $0.00 | - | |
| Bradley Evan Burnam - Officer | Gift | Common Stock | 300,000 | $0.00 | - | |
| Bradley Evan Burnam - Officer | Gift | Common Stock | 300,000 | $0.00 | - | |
| Bradley Evan Burnam - Officer | Gift | Common Stock | 300,000 | $0.00 | - | |
| Bradley Evan Burnam - Officer | Gift | Common Stock | 300,000 | $0.00 | - | |
| Arthur F. Golden - Director | Gift | Common Stock | 300,000 | $0.00 | - | |
| Zuraiz Chaudhary - Officer | Grant or award | Employee stock option (right to buy) | 80,000 | $0.00 | - | |
| Martin William Dewhurst - Director | Grant or award | Common Stock | 21,882 | $0.00 | - | |
| Zuraiz Chaudhary - Officer | Open-market purchase | Common Stock | 2,500 | $3.50 | $9K | |
| Arthur F. Golden - Director | Open-market purchase | Common Stock | 9,868 | $3.44 footnote F2 | $34K | |
| ||||||
| Arthur F. Golden - Director | Open-market purchase | Common Stock | 20,532 | $2.87 footnote F2 | $59K | |
| ||||||
| Zuraiz Chaudhary - Officer | Open-market purchase | Common Stock | 1,450 | $2.61 | $4K | |
| Zuraiz Chaudhary - Officer | Open-market purchase | Common Stock | 1,000 | $3.29 | $3K | |
| Zuraiz Chaudhary - Officer | Open-market purchase | Common Stock | 2,500 | $3.62 footnote F1 | $9K | |
| ||||||
 Abraham Chesed | Open-market purchase | Common Stock | 14,286 | $4.60 | $66K | |
| Zuraiz Chaudhary - Officer | Open-market purchase | Common Stock | 5,050 | $4.95 | $25K | |
| Arthur F. Golden - Director | Open-market purchase | Common Stock | 20,202 | $4.95 | $100K | |
 Neilesh Shailesh Ghodadra - Officer | Grant or award | Common Stock | 10,000 | $0.00 | - | |
| Kent Edward Kester - Director | Grant or award | Common Stock | 10,000 | $0.00 | - | |
| Zuraiz Chaudhary - Officer | Grant or award | Employee stock option (right to buy) | 240,000 | $0.00 | - | |
| Andrew Gengos - Director | Grant or award | Common Stock | 10,000 | $0.00 | - | |
| Arthur F. Golden - Director | Grant or award | Common Stock | 10,000 | $0.00 | - | |
TTRX insider trading FAQ
What is the latest insider trade for TTRX?
Turn Therapeutics Inc. (TTRX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-08. The full record for TTRX runs to 22 Form 4 filings, the earliest from 2025-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TTRX stock?
No insider purchases of TTRX were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling TTRX stock?
No insider sales of TTRX were filed in the last 90 days.
Where can I see TTRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TTRX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Martin William Dewhurst view on EDGAR
- - Andrew Gengos view on EDGAR
- - Arthur F. Golden view on EDGAR
- - Kent Edward Kester view on EDGAR
- - Bradley Evan Burnam view on EDGAR
- - Bradley Evan Burnam view on EDGAR
- - Arthur F. Golden view on EDGAR
- - Zuraiz Chaudhary view on EDGAR
- - Martin William Dewhurst view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TTRX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TTRX with a 7-day demo
- TTRX on your watchlist
- Every TTRX Form 4 filing on record
- Up to 3 months of TTRX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
